A A Odutola

Summary

Affiliation: Medical Research Council Laboratories
Country: The Gambia

Publications

  1. doi Risk factors for delay in age-appropriate vaccinations among Gambian children
    Aderonke Odutola
    Medical Research Council Unit, PO Box 273, Banjul, Fajara, The Gambia
    BMC Health Serv Res 15:346. 2015
  2. pmc Lessons in participant retention in the course of a randomized controlled clinical trial
    Olubukola T Idoko
    Medical Research Council Unit, P, O Box 273, Banjul, The Gambia
    BMC Res Notes 7:706. 2014
  3. pmc Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infants
    Aderonke Odutola
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    PLoS ONE 8:e75558. 2013
  4. doi A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
    A A Odutola
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    Vaccine 30:5591-4. 2012

Collaborators

  • Brian Greenwood
  • M O C Ota
  • Olubukola T Idoko
  • Gibbi Sey
  • Olatunde Ogundare
  • Yauba Saidu
  • Archibald Worwui
  • Alison Smith-Sanneh
  • Philip Mendy
  • Assan Sanyang
  • Olumuyiwa A Owolabi
  • Abdoulie Tunkara

Detail Information

Publications4

  1. doi Risk factors for delay in age-appropriate vaccinations among Gambian children
    Aderonke Odutola
    Medical Research Council Unit, PO Box 273, Banjul, Fajara, The Gambia
    BMC Health Serv Res 15:346. 2015
    ..We studied the timeliness of routine vaccinations among children aged 12-59 months attending infant welfare clinics in semi-urban areas of The Gambia, a country with high vaccine coverage...
  2. pmc Lessons in participant retention in the course of a randomized controlled clinical trial
    Olubukola T Idoko
    Medical Research Council Unit, P, O Box 273, Banjul, The Gambia
    BMC Res Notes 7:706. 2014
    ..This article shares experiences from a phase II trial that recorded a high retention rate at 14 months follow-up at a new clinical trial site...
  3. pmc Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of gambian infants
    Aderonke Odutola
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    PLoS ONE 8:e75558. 2013
    ..Therefore, trials of pneumococcal protein vaccines need to evaluate their impact on carriage of other potentially pathogenic bacteria in addition to the pneumococcus...
  4. doi A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
    A A Odutola
    Vaccinology Theme, Medical Research Council Unit, Banjul, The Gambia
    Vaccine 30:5591-4. 2012
    ..All the children had negligible evidence of latent infection with M. tuberculosis (Mtb), suggesting that deploying a prophylactic vaccine against Mtb infection at this age could still be effective in this setting...